SOLACI & SBHCI 2026 Concludes Successfully; Kossel Expands Partnership Footprint Across South America
Held in São Paulo, Brazil from July 29 to 31, 2026, SOLACI & SBHCI 2026 stands as the flagship annual event for cardiovascular intervention across Latin America. The conference brought together leading global specialists in panvascular intervention, clinicians and industry distributors. Through academic forums, hands-on training sessions and product exhibitions, participants explored new pathways for […]
Kossel Makes a Stunning Debut on the Global Medical Stage — A Successful Wrap-up of CVIT 2026!
From July 16 to 18, 2026, the 34th Annual Meeting of the Japanese Cardiovascular Intervention Therapeutics (CVIT 2026) was successfully held at Tokyo International Forum. The conference brought together top clinical specialists, researchers and leading industry players worldwide to discuss cutting-edge advances and future trends in minimally invasive interventional diagnosis and treatment. With years of […]
Good News | Selepump® Inflation Device Receives PMDA Approval in Japan
Following its successful registration with Singapore’s Health Sciences Authority (HSA), Kossel Medtech’s Selepump® Inflation Device has now obtained approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA), officially gaining access to the Japanese market. With this latest milestone, Selepump® has secured four major international regulatory approvals, including EU CE 2797, U.S. FDA, Singapore HSA, and […]
Good News | Selepump® Inflation Device Receives HSA Approval in Singapore
Recently, Selepump® Inflation Device, developed by Kossel Medtech (Suzhou) Co., Ltd., has successfully obtained market approval from the Singapore Health Sciences Authority (HSA), officially gaining access to the Singapore market. With this latest approval, the product now holds three internationally recognized certifications—EU CE 2797, U.S. FDA clearance, and Singapore HSA registration—further expanding its global market […]
Good News | Expanding Footprint in Southeast Asia: Selethru® PTCA Balloon Dilatation Catheter Secures Singapore Registration Approval
Recently, Selethru® PTCA Balloon Dilatation Catheter, independently developed by Kossel Medtech, has obtained official marketing approval from Singapore’s Health Sciences Authority (HSA). This milestone further optimizes the Company’s strategic layout across Southeast Asia and accelerates its global expansion drive. As a hub for medical innovation in Southeast Asia, Singapore boasts world-leading medical regulatory frameworks and […]
Uniting Asia-Pacific, Forging New Horizons | Kossel Makes Stunning Appearance at APSCVIR 2026
From June 11 to 14, the 20th Annual Scientific Meeting of Asia Pacific Society of Cardiovascular and Interventional Radiology (APSCVIR 2026) grandly took place at Suzhou International Expo Center. The conference brought together top clinical specialists, research scholars and leading industrial enterprises from home and abroad to discuss cutting-edge advances and future trends in minimally invasive […]
Good News | Two Peripheral Balloon Catheters Obtain Hong Kong SAR Registration Certificates, Kossel Medtech Accelerates Global Layout
Recently, Falspeed® PTA Balloon Dilatation Catheter and Falexpand® HP PTA Balloon Dilatation Catheter, two independently developed products by Kossel Medtech, have officially secured registration certification from the Department of Health of the Hong Kong Special Administrative Region (HKSAR), granting approval for marketing and sales in Hong Kong. As an Asian hub for medical innovation and […]
Good News | K-VisionMax™ Peripheral IVUS System Approved for Market Launch, Empowering Precision Diagnosis and Treatment!
Previously, Kossel Medtech (Suzhou) Co., Ltd. (hereinafter referred to as “Kossel Medtech”) completed the strategic acquisition of the peripheral vascular intervention business of Shanghai Biotriton Medical Technology Co., Ltd (hereinafter referred to as “Biotriton Medical”), further strengthening Kossel Medtech’s comprehensive one-stop diagnosis and treatment portfolio in the peripheral intervention field. Recently, Biotriton Medical’s independently developed […]
Kossel Acquires XINZHI MEDICAL to Expand Drug-Coated Balloon Portfolio and Strengthen Its Position in Coronary Intervention
Introduction Kossel Medtech (Suzhou) Co., Ltd. (“Kossel”) has completed the acquisition of Shanghai Xinzhi Medical Technology Co., Ltd. (“XINZHI MEDICAL”), marking a key strategic step in its transformation from a leading peripheral intervention company into a comprehensive vascular intervention platform. The acquisition significantly strengthens Kossel’s drug-coated balloon (DCB) technology platform by adding both sirolimus-coated and […]
Kossel × Biotriton: Deepening the Peripheral Vascular Intervention Ecosystem and Advancing a Long-Term, Sustainable Growth Strategy
The history of the global medical device industry demonstrates that mergers and acquisitions are a defining pathway for the growth of leading enterprises. International companies such as Medtronic have continuously strengthened their market positions and secured high-growth opportunities through strategic acquisitions. Today, China’s medical device industry is entering a new phase of consolidation and collaborative […]